# A Multicenter, Randomized, Double-blind Non-inferiority Trial to Evaluate the Efficacy and Safety of Entelon®

> **NCT03962296** · PHASE4 · COMPLETED · sponsor: **Hanyang University** · enrollment: 153 (actual)

## Conditions studied

- Diabetic Retinopathy

## Interventions

- **DRUG:** Vitis vinifera extract
- **DRUG:** Calcium Dobesilate
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT03962296
- **Lead sponsor:** Hanyang University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-11-21
- **Primary completion:** 2015-01-26
- **Final completion:** 2015-01-26
- **Target enrollment:** 153 (ACTUAL)
- **Last updated:** 2019-05-24

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03962296

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03962296, "A Multicenter, Randomized, Double-blind Non-inferiority Trial to Evaluate the Efficacy and Safety of Entelon®". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT03962296. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*